The global aortic aneurysm market was analysed by Market Research Future (MRFR) and it was projected that a notable CAGR of 8.4% will be attained by the market over the forecast period. The valuation of the market was further stated to surpass its previous valuation USD 2,357.6 million in 2017 by the end of the forecast period.
The global market is growing due to factors like increasing penetration of tobacco smoking in both developing as well as developed countries, growing elderly population across the globe, supportive reimbursement scenarios for surgical treatment of aortic aneurysms, the increasing prevalence of cardiovascular diseases, and rising technological advancements in products. On the other hand, the low reimbursement rates present in developing nations and high pricing level of aortic aneurysm market treatment and devices can hinder the market growth in the next few years.
The global aortic aneurysm market has been segmented in terms of type, end-user, treatment, and product.
- Abdominal Aortic Aneurysm (AAA)
- Thoracic Aortic Aneurysm (TAA)
- Endovascular Aneurysm Repair (EVAR)
- Open Surgical Repair (OSR)
By End user
- Ambulatory Surgery Centers (ascs)
- Hospitals & Clinics
The global aortic aneurysm market comprises a host of key players. This includes names like
- Lombard Medical Limited
- Microport Scientific Corporation
- Medtronic PLC
- MAQUET Holding B.V. & Co. KG
- Terumo Medical Corporation
- Cook Medical
- W. L. Gore & Associates
- Endologix, Inc.
- JO0TEC AG (CryoLife, Inc.),
- Cardinal Health, Inc.
The global aortic aneurysm market is geographically distributed across the following key regions: Asia Pacific, Americas, Europe, and the Rest of the World (RoW).
The Americas is expected to continue its dominance of the aortic aneurysm market during the forecast period. This is attributed to the presence of major market vendors, established medical and healthcare infrastructure and facilities, increasing spending level in the healthcare industry, and consistent launches of novel devices across developed nations like the US and Canada.
Europe is said to be the second-largest contributor to the global market of aortic aneurysm due to the massive prevalence of tobacco smoking herein and the number of favorable initiatives by several organizations to curb down the burden of aortic aneurysm. To paint a better picture, the World Health Organization (WHO) said that at present, Europe holds the highest prevalence of tobacco smoking amongst adult citizens (28%) and even some of the highest prevalence of tobacco use by adolescents.
Asia-Pacific is most likely to experience the fastest growth in the aortic aneurysm market during the assessment period. This is because of the growing geriatric population herein and the booming prevalence of cardiovascular diseases & hypertension diseases, widespread awareness about aortic aneurysm treatment, and the developing healthcare infrastructure across key nations like India, China, and Australia. For instance, WHO reported recently that over one million people in the Western Pacific Region succumb to death each year from cardiovascular diseases, one which is caused due to the use of tobacco.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312